Skip to content
healthcare.dev

oxcarbazepine

NDC 33342-259, oxcarbazepine, for suspension, from Macleods Pharmaceuticals Limited.

Product NDC
33342-259
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207300
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-259 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE300 mg/5mL

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
33342-259-67333420259671 BOTTLE in 1 CARTON (33342-259-67) / 250 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/962098cc-2d84-4723-a296-b110f1fd659e

Use it

Look up 33342-259 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-259 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-259. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.